Obesity in the U.S. has grown significantly over the past few decades, with the prevalence increasing from 47% to 58% between 1999 and 2020. To address this, GLP-1/GIP peptides—such as Semaglutide, Tirzepatide, and Retatrutide—have emerged as a promising solution for supporting weight loss and improving blood sugar control. These peptides mimic the natural GLP-1 hormone produced in the body, helping regulate appetite, blood sugar, and fat metabolism. To maximize their benefits and minimize side effects, a holistic approach is recommended, focusing on resistance training, adequate protein intake, and micronutrient optimization.
GLP-1 receptor agonists and GIP peptides mimic natural hormones that regulate glucose metabolism and appetite. They work by:
Resistance training is key for maintaining lean muscle mass and enhancing fat loss when using GLP1/GIP peptides.
Scientific Evidence on Resistance Training:
Incorporating resistance training into a weight loss plan ensures that lean muscle is preserved, which helps maintain metabolism and supports long-term weight loss.
To optimize the effects of GLP-1s and GIP peptides, adequate protein intake is essential for building and maintaining muscle mass during weight loss.
Scientific Evidence on Protein & Weight Loss:
General recommendations suggest aiming for 0.8-1.0 grams of protein per pound of ideal body weight to support muscle repair and prevent muscle breakdown.
While GLP-1/GIP peptides are effective for weight loss, they can cause gastrointestinal side effects like nausea or constipation. Micronutrient optimization helps minimize these effects and supports gut motility—the movement of food through the digestive system..
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.